WuXi PharmaTech Schedules Fourth-Quarter 2012 Earnings Release

        WuXi PharmaTech Schedules Fourth-Quarter 2012 Earnings Release

PR Newswire

SHANGHAI, Feb. 8, 2013

SHANGHAI, Feb. 8, 2013 /PRNewswire/ -- WuXi PharmaTech (Cayman) Inc. (NYSE:
WX), a leading pharmaceutical, biotechnology and medical device R&D
outsourcing company with operations in China and the United States, today
announced that it will release financial results for the fourth quarter of
2012 after the New York Stock Exchange closes on Thursday, March 7, 2013
(which will be Friday morning, March 8, 2013 Shanghai time). The earnings
release will be available on the investor relations section of the Company's
website at http://www.wuxiapptec.com/.

Following the earnings announcement, WuXi PharmaTech senior management will
host a conference call at 8:00 am (U.S. Eastern) / 5:00 am (U.S. Pacific) /
9:00 pm (Beijing/Shanghai/Hong Kong) on Friday, March 8, 2013, to discuss the
fourth-quarter 2012 financial results and recent business activities. The
conference call may be accessed by calling:

United States:    1-866-519-4004
China (Landline): 800-819-0121
China (Mobile):   400-620-8038
Hong Kong:        800-930-346
United Kingdom:   0-808-234-6646
International:    +65-6723-9381
Conference ID:    99349171

A telephone replay will be available two hours after the call's completion at:

United States:    1-855-452-5696
China (Landline): 800-870-0205
China (Mobile):   400-120-0932
Hong Kong:        800-963-117
United Kingdom:   0-808-234-0072
International:    +61-2-8199-0299
Conference ID:    99349171

A live webcast of the conference call and replay will be available in the
investor relations section of WuXi PharmaTech's website at
http://www.wuxiapptec.com/.

About WuXi PharmaTech

WuXi PharmaTech is a leading pharmaceutical, biotechnology and medical device
R&D outsourcing company, with operations in China and the United States. As a
research-driven and customer-focused company, WuXi PharmaTech provides
pharmaceutical, biotechnology and medical device companies with a broad and
integrated portfolio of laboratory and manufacturing services throughout the
drug and medical device R&D process. WuXi PharmaTech's services are designed
to help its global partners in shortening the cycle and lowering the cost of
drug and medical device R&D. The operating subsidiaries of WuXi PharmaTech are
known as WuXi AppTec.

For more information, please contact:

Ronald Aldridge
Director of Investor Relations
WuXi PharmaTech (Cayman) Inc.
Tel: +1-201-585-2048
Email: Ron_Aldridge@wuxiapptec.com
Web: http://www.wuxiapptec.com

SOURCE Wuxi PharmaTech Co. Ltd.

Website: http://www.wuxiapptec.com